Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05336786 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of May 26, 2026 to May 26, 2025
    • Site details revised at 2 of 2 sites
    • Collaborators expanded, about 4 words
    v10
  2. 2 versions Re-verified since Apr 28, 2025, no change to tracked fieldsv8-v9
  3. Enrollment target: 50 to 70
    • Study description revised
    • Site details revised at 1 of 2 sites
    v7
  4. Primary completion date: Jun 26, 2024 to May 26, 2026
    • Study completion date: Aug 31, 2024 to May 26, 2026
    v6
  5. Primary completion date: May 26, 2026 to Jun 26, 2024
    • Study completion date: May 26, 2026 to Aug 31, 2024
    • Study title shortened, about 6 words
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 1 to 2v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 26, 2022 to Jun 15, 2022
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase III trial investigates if perflutren lipid microspheres with ultrasound can be used to diagnose prostate cancer non-invasively. Definity (perflutren lipid microspheres) is an ultrasound contrast agent that is typically used for ultrasound bubble studies that involve the heart. Definity appears on ultrasound images as tiny gas-filled microbubbles. These microbubbles are about the size of a red blood cell and do not stay in a patient's body for more than several minutes, where they are excreted from the lungs and exhaled back into the air when breathing. Definity may enhance ultrasound images of the prostate and help doctors identify prostate cancer on ultrasound images.
Trial Details
NCT Number NCT05336786
Lead Sponsor Thomas Jefferson University
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Prostate Carcinoma
Related terms Prostatic Neoplasms
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov